drug · small molecule
Wiskott-Aldrich Syndrome
Phase 2updated 3mo agoby Genethon SA🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 3 approved and 19 investigational indications.
targets
Thrombopoietin receptor
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 1h ago
Found something off?
comments(0)
5-min edit window · permanent after that